Dr. Davis leads Cincinnati Children’s, a $3.3 billion nonprofit pediatric academic health system with a workforce of nearly 20,000. The system recorded 1.75 million patient encounters in fiscal year 2024-25, including children from all 50 states and dozens of countries. He previously served six years as the health system’s COO before becoming president and CEO. Under his leadership, Cincinnati Children’s has consistently ranked among the top pediatric hospitals in the nation on U.S. News & World Report’s “Best Children’s Hospitals” honor roll and is the No. 3 recipient of pediatric research grants from the National Institutes of Health, with sponsored awards totaling more than $304 million annually. In 2021, he helped launch HealthVine, a network of pediatric care providers that coordinates care and support services for more than 127,000 children and families across southwest Ohio. Dr. Davis has also positioned Cincinnati Children’s as a global leader in proton therapy research, including the world’s first clinical trials investigating FLASH radiotherapy, and supported a $99 million inpatient mental health facility that is the largest of its kind in the nation. Most recently, the health system opened the Winslow Research Pavilion, one of only 10 NIH-funded vaccine and treatment evaluation units in the country and the only one housed at a freestanding pediatric hospital. Dr. Davis also chairs the board of the Ohio Children’s Hospital Association and is a board member of Children’s Hospitals’ Solutions for Patient Safety.
